AAFP Antibiotics for Acute Uncomplicated Diverticulitis Does antibiotic therapy for acute uncomplicated diverticulitis reduce complications and the need for emergency surgery? September 15, 2023
AAFP Antibiotics for Acute Uncomplicated Diverticulitis Does antibiotic therapy for acute uncomplicated diverticulitis reduce complications and the need for emergency surgery? September 15, 2023
Evaluation of factors predicting successful outcome in patients scheduled for treatment of acute uncomplicated appendicitis
specialty Please chooseI’m not a medical professional.Allergy and immunologyanatomyanesthesiologyCardiac, thoracic, and vascular surgerycardiologyCritical caredentalDermatologyDiabetes and endocrinologyemergency medical careepidemiology and public healthRegular medicineForensic medicineDepartment of GastroenterologyGeneral medical treatmentgeneticsgeriatricsmedical policyHematologyHIV/AIDShospital-based medical careI’m not a medical professional.InfectionIntegrative medicine/complementary medicineInternal medicineInternal medicine/pediatricsMedical education and simulationmedical physicsmedical studentnephrologyneurosurgeryneurologynuclear medicinenutritionObstetrician and gynecologistoccupational healthoncologyophthalmologyoptometryOral medicineorthopedic surgeryosteopathic medicineOtorhinolaryngologypain managementpalliative carePathologyPediatricspediatric surgeryPhysical therapy and […]
It may be safe to delay surgical intervention for 24 hours in patients with uncomplicated appendicitis
1. In patients diagnosed with simple appendicitis, surgery within 24 hours was noninferior to surgery within 8 hours with respect to the risk of appendiceal perforation. 2. There were no deaths reported in either group. Evidence evaluation level: 1 (great) research summary: Appendectomy or appendectomy is the standard treatment for appendicitis, but there is no […]
Eubiotic effects of rifaximin are associated with reduced abdominal pain in symptomatic uncomplicated diverticular disease: results of an observational cohort study | BMC Gastroenterology
To our knowledge, this study is the first to evaluate the long-term (i.e., 6 months) effects of rifaximin on the gut microbiota of SUDD patients. Here we show that rifaximin significantly reduced the severity of abdominal pain, which is consistent with previous studies. [9,10,11,12]. Treatment with rifaximin over 6 months was not associated with significant […]